Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Sale and Maturity of Investments (2020 - 2026)

Updated

Aligos Therapeutics' Sale and Maturity of Investments - Total came in at $25 million for Q2 2026, down 28.6% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics' Sale and Maturity of Investments - Total was $127.5 million, up 41.7% from FY2024.

  • Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
  • Going back by year, Sale and Maturity of Investments - Total was $90.01 million in FY2024 (+99.5%), $45.11 million in FY2023 (-42.8%), $78.86 million in FY2022 (+244.5%) and $22.89 million in FY2021 (-71.4%).
  • The Q2 2026 figure represents the lowest quarterly Sale and Maturity of Investments - Total since Q1 2025.
  • Business Quant data shows ALGS's Sale and Maturity of Investments - Total at $35 million (Q1 2026), $37.5 million (Q4 2025) and $70 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.00 Mn
Mar 31, 2026 35.00 Mn
Dec 31, 2025 37.50 Mn
Sep 30, 2025 70.00 Mn
Mar 31, 2025 20.00 Mn
Dec 31, 2024 19.98 Mn
Sep 30, 2024 30.08 Mn
Jun 30, 2024 18,000.00
Mar 31, 2024 -69,000.00
Dec 31, 2023 -44.92 Mn
Sep 30, 2023 11,000.00
Jun 30, 2023 25.00 Mn
Mar 31, 2023 20.00 Mn
Dec 31, 2022 -42.75 Mn
Sep 30, 2022 37.45 Mn
Jun 30, 2022 5.49 Mn
Mar 31, 2022 -248,000.00
Dec 31, 2021 -13.11 Mn
Sep 30, 2021 3.00 Mn
Mar 31, 2021 20.00 Mn
API Access

Aligos Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY